2019 is the worst year for Johnson & Johnson (NYSE:JNJ). The company is ordered to pay $8 billion in punitive damages by the jury after it failed to warn the young boy over the side effects of an anti-psychoactive drug – Risperdal. According to the filing, Johnson & Johnson has pushed the doctors to prescribe […]
Michael Santoro
Recent Posts
BLUE WATER PETROLEUM THERMO VARNISH PRODUCT UPDATE
FREEDOM HOLDINGS ANNOUNCES MANAGEMENT HAS COMPLETED FINANCIAL REPORTS
Jose Cuervo Joins Forces With Arma and Sureco to Develop Green Carbon Methodology for Agave Plants Used in Tequila Production
Nate’s Food Co. Declares Cash Dividend for Shareholders from Successful Bitcoin Mining Operations
Green Stream Holdings, Inc., Enters Into EV Charging Station Installation and Management Agreement With New Supplier “Qovoltis”
Popular Post
-
InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand of FDA-Registered OTC Rechargeable Hearing Aids on Target.com
-
Sports Gambling and the Horse Racing Market
-
ZICIX+CTIP-FII RECEIVES NOTICE TO PROCEED FROM PROJECT OWNER TO START THE $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEY
-
Mass Megawatts Targets Solar Customers throughout the Northeast and its Solar Tracker’s Time of Use (TOU) Rates Advantages Become More Important When California’s NEM 3 Takes Effect Next Month
-
Principal Solar to Acquire Minerva-Rockdale Leases, Wells, and Assets
